P.162 Effects of Systemic Corticosteroid Treatment on Pseudotumoral Hemicerebellitis
Background: Pseudotumoral hemicerebellitis is an acute, unilateral inflammation of the cerebellum that typically affects the pediatric population. The etiology remains to be elucidated, however frequently is attributed to post-infectious inflammation. Though it tends to be self-resolving, treatment...
Gespeichert in:
Veröffentlicht in: | Canadian journal of neurological sciences 2021-11, Vol.48 (s3), p.S66-S66 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S66 |
---|---|
container_issue | s3 |
container_start_page | S66 |
container_title | Canadian journal of neurological sciences |
container_volume | 48 |
creator | Vivekanandan, A Santyr, B Ranger, A |
description | Background: Pseudotumoral hemicerebellitis is an acute, unilateral inflammation of the cerebellum that typically affects the pediatric population. The etiology remains to be elucidated, however frequently is attributed to post-infectious inflammation. Though it tends to be self-resolving, treatment may reduce the time to symptomatic recovery. Systemic corticosteroid therapy has been proposed as a mechanism for improving outcomes and time to symptomatic recovery. Methods: We present a case report of a 12-year-old male with pseudotumoral hemicerebellitis and unilateral cerebellar dysfunction. Additionally, we briefly review the additional 35 reported cases of pseudotumoural hemicerebellitis with respect to length of time to symptomatic recovery with or without systemic corticosteroid treatment. Results: 30 cases reported length of time to symptomatic recovery. Including our case, the mean time to recovery for those treated with systemic corticosteroids (n=20) was 48.05 days(SE=16.3). The mean time to recovery for those treated without (n=10) was 86.7 days(SE=29.3). Conclusions: Treatment with systemic corticosteroids was associated with a faster time to symptomatic recovery compared to without. Regardless of etiology, reducing inflammation and mass effect involved in pseudotumoral hemicerebellitis may be integral to a more rapid return to neurological baseline. |
doi_str_mv | 10.1017/cjn.2021.438 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2793937501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_cjn_2021_438</cupid><sourcerecordid>2793937501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1428-c0c9409c0dbf4b0f5c5b2136649653e183c4bc47908409d1ef2633a8590844e23</originalsourceid><addsrcrecordid>eNptkE1Lw0AQhhdRsFZv_oAFrybu9yZHKdUKBQvW85JsZiUlydbdzaH_3oQKXjwNMzzvO_AgdE9JTgnVT_Yw5IwwmgteXKAFI1JnhEp5iRaEU51Rpek1uonxQAhTUokF2u9yqhheOwc2Rewd_jjFBH1r8cqH1Fo_bcG3Dd4HqFIPQ8J-wLsIY-PT2PtQdXgz8xCghq5rUxtv0ZWrugh3v3OJPl_W-9Um276_vq2et5mlghWZJbYUpLSkqZ2oiZNW1oxypUSpJAdacCtqK3RJiglrKDimOK8KOR8EML5ED-feY_DfI8RkDn4Mw_TSMF3ykmtJ6EQ9nikbfIwBnDmGtq_CyVBiZm9m8mZmb2byNuH5L171dWibL_hr_TfwAwPAbmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2793937501</pqid></control><display><type>article</type><title>P.162 Effects of Systemic Corticosteroid Treatment on Pseudotumoral Hemicerebellitis</title><source>Cambridge University Press Journals Complete</source><creator>Vivekanandan, A ; Santyr, B ; Ranger, A</creator><creatorcontrib>Vivekanandan, A ; Santyr, B ; Ranger, A</creatorcontrib><description>Background: Pseudotumoral hemicerebellitis is an acute, unilateral inflammation of the cerebellum that typically affects the pediatric population. The etiology remains to be elucidated, however frequently is attributed to post-infectious inflammation. Though it tends to be self-resolving, treatment may reduce the time to symptomatic recovery. Systemic corticosteroid therapy has been proposed as a mechanism for improving outcomes and time to symptomatic recovery. Methods: We present a case report of a 12-year-old male with pseudotumoral hemicerebellitis and unilateral cerebellar dysfunction. Additionally, we briefly review the additional 35 reported cases of pseudotumoural hemicerebellitis with respect to length of time to symptomatic recovery with or without systemic corticosteroid treatment. Results: 30 cases reported length of time to symptomatic recovery. Including our case, the mean time to recovery for those treated with systemic corticosteroids (n=20) was 48.05 days(SE=16.3). The mean time to recovery for those treated without (n=10) was 86.7 days(SE=29.3). Conclusions: Treatment with systemic corticosteroids was associated with a faster time to symptomatic recovery compared to without. Regardless of etiology, reducing inflammation and mass effect involved in pseudotumoral hemicerebellitis may be integral to a more rapid return to neurological baseline.</description><identifier>ISSN: 0317-1671</identifier><identifier>EISSN: 2057-0155</identifier><identifier>DOI: 10.1017/cjn.2021.438</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Inflammation ; Neuro-oncology ; Neurosurgery (CNSS) ; Poster Presentations ; Steroids</subject><ispartof>Canadian journal of neurological sciences, 2021-11, Vol.48 (s3), p.S66-S66</ispartof><rights>The Author(s), 2021. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0317167121004388/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,27924,27925,55628</link.rule.ids></links><search><creatorcontrib>Vivekanandan, A</creatorcontrib><creatorcontrib>Santyr, B</creatorcontrib><creatorcontrib>Ranger, A</creatorcontrib><title>P.162 Effects of Systemic Corticosteroid Treatment on Pseudotumoral Hemicerebellitis</title><title>Canadian journal of neurological sciences</title><addtitle>Can. J. Neurol. Sci</addtitle><description>Background: Pseudotumoral hemicerebellitis is an acute, unilateral inflammation of the cerebellum that typically affects the pediatric population. The etiology remains to be elucidated, however frequently is attributed to post-infectious inflammation. Though it tends to be self-resolving, treatment may reduce the time to symptomatic recovery. Systemic corticosteroid therapy has been proposed as a mechanism for improving outcomes and time to symptomatic recovery. Methods: We present a case report of a 12-year-old male with pseudotumoral hemicerebellitis and unilateral cerebellar dysfunction. Additionally, we briefly review the additional 35 reported cases of pseudotumoural hemicerebellitis with respect to length of time to symptomatic recovery with or without systemic corticosteroid treatment. Results: 30 cases reported length of time to symptomatic recovery. Including our case, the mean time to recovery for those treated with systemic corticosteroids (n=20) was 48.05 days(SE=16.3). The mean time to recovery for those treated without (n=10) was 86.7 days(SE=29.3). Conclusions: Treatment with systemic corticosteroids was associated with a faster time to symptomatic recovery compared to without. Regardless of etiology, reducing inflammation and mass effect involved in pseudotumoral hemicerebellitis may be integral to a more rapid return to neurological baseline.</description><subject>Inflammation</subject><subject>Neuro-oncology</subject><subject>Neurosurgery (CNSS)</subject><subject>Poster Presentations</subject><subject>Steroids</subject><issn>0317-1671</issn><issn>2057-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptkE1Lw0AQhhdRsFZv_oAFrybu9yZHKdUKBQvW85JsZiUlydbdzaH_3oQKXjwNMzzvO_AgdE9JTgnVT_Yw5IwwmgteXKAFI1JnhEp5iRaEU51Rpek1uonxQAhTUokF2u9yqhheOwc2Rewd_jjFBH1r8cqH1Fo_bcG3Dd4HqFIPQ8J-wLsIY-PT2PtQdXgz8xCghq5rUxtv0ZWrugh3v3OJPl_W-9Um276_vq2et5mlghWZJbYUpLSkqZ2oiZNW1oxypUSpJAdacCtqK3RJiglrKDimOK8KOR8EML5ED-feY_DfI8RkDn4Mw_TSMF3ykmtJ6EQ9nikbfIwBnDmGtq_CyVBiZm9m8mZmb2byNuH5L171dWibL_hr_TfwAwPAbmA</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Vivekanandan, A</creator><creator>Santyr, B</creator><creator>Ranger, A</creator><general>Cambridge University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>202111</creationdate><title>P.162 Effects of Systemic Corticosteroid Treatment on Pseudotumoral Hemicerebellitis</title><author>Vivekanandan, A ; Santyr, B ; Ranger, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1428-c0c9409c0dbf4b0f5c5b2136649653e183c4bc47908409d1ef2633a8590844e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Inflammation</topic><topic>Neuro-oncology</topic><topic>Neurosurgery (CNSS)</topic><topic>Poster Presentations</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vivekanandan, A</creatorcontrib><creatorcontrib>Santyr, B</creatorcontrib><creatorcontrib>Ranger, A</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Canadian journal of neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vivekanandan, A</au><au>Santyr, B</au><au>Ranger, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P.162 Effects of Systemic Corticosteroid Treatment on Pseudotumoral Hemicerebellitis</atitle><jtitle>Canadian journal of neurological sciences</jtitle><addtitle>Can. J. Neurol. Sci</addtitle><date>2021-11</date><risdate>2021</risdate><volume>48</volume><issue>s3</issue><spage>S66</spage><epage>S66</epage><pages>S66-S66</pages><issn>0317-1671</issn><eissn>2057-0155</eissn><abstract>Background: Pseudotumoral hemicerebellitis is an acute, unilateral inflammation of the cerebellum that typically affects the pediatric population. The etiology remains to be elucidated, however frequently is attributed to post-infectious inflammation. Though it tends to be self-resolving, treatment may reduce the time to symptomatic recovery. Systemic corticosteroid therapy has been proposed as a mechanism for improving outcomes and time to symptomatic recovery. Methods: We present a case report of a 12-year-old male with pseudotumoral hemicerebellitis and unilateral cerebellar dysfunction. Additionally, we briefly review the additional 35 reported cases of pseudotumoural hemicerebellitis with respect to length of time to symptomatic recovery with or without systemic corticosteroid treatment. Results: 30 cases reported length of time to symptomatic recovery. Including our case, the mean time to recovery for those treated with systemic corticosteroids (n=20) was 48.05 days(SE=16.3). The mean time to recovery for those treated without (n=10) was 86.7 days(SE=29.3). Conclusions: Treatment with systemic corticosteroids was associated with a faster time to symptomatic recovery compared to without. Regardless of etiology, reducing inflammation and mass effect involved in pseudotumoral hemicerebellitis may be integral to a more rapid return to neurological baseline.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><doi>10.1017/cjn.2021.438</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0317-1671 |
ispartof | Canadian journal of neurological sciences, 2021-11, Vol.48 (s3), p.S66-S66 |
issn | 0317-1671 2057-0155 |
language | eng |
recordid | cdi_proquest_journals_2793937501 |
source | Cambridge University Press Journals Complete |
subjects | Inflammation Neuro-oncology Neurosurgery (CNSS) Poster Presentations Steroids |
title | P.162 Effects of Systemic Corticosteroid Treatment on Pseudotumoral Hemicerebellitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A08%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P.162%20Effects%20of%20Systemic%20Corticosteroid%20Treatment%20on%20Pseudotumoral%20Hemicerebellitis&rft.jtitle=Canadian%20journal%20of%20neurological%20sciences&rft.au=Vivekanandan,%20A&rft.date=2021-11&rft.volume=48&rft.issue=s3&rft.spage=S66&rft.epage=S66&rft.pages=S66-S66&rft.issn=0317-1671&rft.eissn=2057-0155&rft_id=info:doi/10.1017/cjn.2021.438&rft_dat=%3Cproquest_cross%3E2793937501%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2793937501&rft_id=info:pmid/&rft_cupid=10_1017_cjn_2021_438&rfr_iscdi=true |